Ohio Bankruptcy Court Adopts “Actual Test” To Determine Whether Certain Unassignable Contracts Can Be Assumed In Bankruptcy

Disagreement regarding the interpretation of section 365(c) of the Bankruptcy Code has led to divergent rulings among the bankruptcy and federal circuit courts regarding whether a bankruptcy trustee or chapter 11 debtor can assume an executory contract or unexpired lease that is unassignable under applicable non-bankruptcy law without the counterparty’s consent—even where the debtor has no intention of assigning the agreement to a third party. Some courts, including several federal circuit courts, have ruled […]

By | October 3rd, 2024 ||

Joe Coleman And John Kane Selected As Global Bankruptcy & Restructuring Leaders In 2024 Lawdragon 500 Guide

Joe Coleman and John Kane were recognized in Lawdragon’s latest 500 Leading Global Bankruptcy & Restructuring Lawyers guide for 2024. Coleman was named a leading lawyer for his work in the area of Insolvency, Bankruptcy & Creditor Rights, and Kane was recognized as a leading lawyer for his work in Bankruptcy & Distressed Asset Litigation.

The guide features leading lawyers accomplished in several areas of financial restructuring, including leveraged finance and restructuring, bankruptcy, and financial litigation. To be […]

By | October 1st, 2024 ||

The Supreme Court’s Rejection Of The Purdue Pharma Bankruptcy Plan And What It Could Mean For Other Mass Tort Bankruptcies In The Child Sex Abuse Context

In late June the Supreme Court handed down Harrington v. Purdue Pharma L.P. a 5-4 decision in which the court made clear the decades-long practice of shielding non-debtors from future claims in exchange for their financial contribution to creditors’ recovery in a Chapter 11 bankruptcy plan was no more. The Sackler family—who long owned and controlled the now infamous maker of OxyContin—had negotiated a $6 billion contribution to Purdue’s bankruptcy as a “settlement” of all claims […]

By | September 27th, 2024 ||